Skip to: Curated Story Group 1
lifesciencesreview

Advertise

with us

  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Topics
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Biomanufacturing
    Business Services
    Business Services
    Business Services
    Business Services
    Business Services
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Drug Discovery
    Pharmacy Management
    Regulatory Services
  • CXO Insights
  • Vendor Viewpoint
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • CXO Awards
OCTOBER 2022LIFE SCIENCES REVIEW9A fascinating angle on CAR-T as an example is that the Intellectual Property is not with the "medicine" but the "methodology" as one can't patent protect someone's personal cells, but only how you do gene transduction/transvection. This is a fascinating paradigm shift in the industry. Truly personalised medicine is about the needs of an individual patient at a specific time, while the same medicine might harm another patient if administered. As such, the biggest single hurdle in development has been the security of the cell line from withdrawal to manipulation to re-administration ­a critical point to reassure Health Care Professional and patients alike.Like several other companies, Kyowa Kirin is active in the immunotherapy space and focused on leveraging such technologies for patients.Personalised medicine for patient-centric careThe opportunities to improve outcomes and personalised care go well beyond medicines. There are exciting new possibilities across the whole care continuum, harnessing novel approaches, such as whole genome sequencing, data and informatics, and wearable technology to help improve diagnosis, treatment, and care. It is the convergence and symbiotic nature of these innovations that make it possible to move to an era of truly personalised care with the patient at the centre of a holistic healthcare approach rather than the Health Care Professional.It is important to note, however, that `personalised healthcare' alone, does not necessarily imply that it is patient-centric. In order to make sure that we achieve the best possible outcomes for patients, it is essential to partner with patients to gather their insights, to inform and empower them to have a meaningful dialogue with their treating physicians about the role that these therapies may play in delivering more value to them while living with a specific disease and in the context of their lives holistically. It is the convergence and symbiotic nature of these innovations that make it possible to move to an era of truly personalised care with the patient at the centre of a holistic healthcare approach rather than the Health Care Professional
< Page 8 | Page 10 >